When Martin Lundberg and Clas Ericsson were diagnosed with prostate cancer, both were advised to consider surgery. Instead of making an immediate decision, they chose to learn more about their options, consult additional specialists, and take time to decide what felt right for them. Their search ultimately led them to Fondazione IRCCS San Gerardo dei Tintori in Monza, Italy, where they received Stereotactic Body Radiation Therapy with the Raypilot System*.


Taking time to explore their options

Martin, 59, from Halland, was diagnosed after persistent requests for a PSA test led to further investigations and the discovery of an aggressive form of prostate cancer. His urologist recommended surgery, but Martin wanted to understand all available options before making a decision.

“I researched extensively online, read everything I could find, and consulted an oncologist. I decided that if the cancer had not spread, I wanted radiation therapy supported by the Raypilot System – even if that meant seeking treatment abroad and potentially paying for it myself.”

Clas, 68, reached a similar crossroads after his prostate cancer was detected through a Stockholm regional screening initiative. When follow-up tests showed treatment was needed, he was also presented with surgery as the preferred option.

“I was told that surgery was required and could be performed within a month. Radiation therapy was presented as an inferior alternative. However, I wanted to learn more and consult additional experts before making such an important decision.”


Clas Ericsson

Choosing treatment in Italy

After speaking with other patients and exploring alternatives, both men chose treatment at Fondazione IRCCS San Gerardo dei Tintori in Monza, Italy.

For Martin, treatment was completed over four days in December 2025.

“Since then, everything has gone very well. I have not experienced a single complication, and I sleep through the night without any problems.”

Clas underwent treatment in February 2026. Although he initially had concerns about the practical aspects of treatment, those concerns quickly disappeared.

“The experience was every bit as professional and positive as others had described. I was concerned about having a catheter in place for four days, but it turned out to be much easier than I expected. I could go to the gym, take walks, sleep well, and experienced no pain or other discomfort.”

Life after treatment

Both men report positive outcomes following treatment.

“I live and feel exactly as I did before treatment. I have not experienced any side effects whatsoever,” says Clas.

Martin has also returned to his normal life, although he acknowledges that living with a cancer diagnosis can bring ongoing uncertainty.

“The experience has left me with a constant underlying sense of stress. I have decided to try to channel that into something positive for others. I want more men to get tested and to be encouraged to do so by healthcare providers rather than discouraged.”

Advice for other patients

Despite their different paths to diagnosis, Martin and Clas share the same advice for other men facing treatment decisions: take the time to understand all available options, seek multiple opinions, and make an informed choice.

“Take your time. Speak to as many specialists as possible. Investigate the possibility of treatment with modern technology and contact those of us who have experience from the same treatment.”


Martin Lundberg


*About the Raypilot System

Conventional prostate radiotherapy often involves around 39-20 treatment sessions. With modern techniques such as Stereotactic Body Radiotherapy (SBRT), treatment can instead be delivered in as few as five sessions, using a higher dose per session.

The prostate is an organ that can move significantly during treatment. As SBRT delivers higher doses in fewer sessions, knowing exactly where the prostate is throughout treatment becomes even more important.

The Raypilot System allows clinicians to continuously monitor the prostate’s position in real time and pause the radiation if it moves outside the planned treatment area. This supports precise radiation delivery, enables smaller treatment margins and helps reduce unnecessary radiation exposure to surrounding healthy tissue.

November Talks

Read interviews, patient journeys, and expert perspectives from November Talks

Continue reading